• About
  • Licensing
  • Podcasting
  • Contact

AudioMedica.com

  • Public Health
  • Oncology
  • Cardiovascular
  • General Medicine

Enoxaparin Shows Safety in Angioplasty – STEEPLE Study

  • — 12 Sep, 2005
AudioMedica News
AudioMedica News
Enoxaparin Shows Safety in Angioplasty - STEEPLE Study
Enoxaparin Shows Safety in Angioplasty - STEEPLE Study
00:00 /
RSS Feed
Share
Link
Embed
Gilles Montalescot
Gilles Montalescot

The STEEPLE trial randomised more than 3500 elective angioplasty patients to unfractionated heparin or either of two dose levels of enoxaparin. Gilles Montalescot presented the findings in Stockholm and talked about them with Audio Medica.
[audio:https://www.audiomedica.com/podcasting/15.Gilles_Montalescot-The_STEEPLE_trial_randomised_more_than_3500_elective_angioplasty_patients.mp3]

Click here for all the interviews from ESC 2005

You may also like...

  • Diabetic Patients: Some Benefits from Fibrates Diabetic Patients: Some Benefits from Fibrates 17 Nov, 2005
  • “RADIANCE-1” Study:  Cholesteryl Ester Transfer Protein Inhibitor Fails to Benefit Patients with Familial Hypercholesterolemia “RADIANCE-1” Study: Cholesteryl Ester Transfer Protein Inhibitor Fails to Benefit Patients with Familial Hypercholesterolemia 27 Mar, 2007
  • Heart Failure Drug Prevents Renal Damage? Heart Failure Drug Prevents Renal Damage? 13 Apr, 2008
  • Transthoracic Echo: A Wasted Test in Stroke Patients? Transthoracic Echo: A Wasted Test in Stroke Patients? 9 Feb, 2007
  • Previous story Drug-eluting Stents: Cost-Benefit Targeting?
  • Next story CIBIS-3 Study: ACE Inhibitor before Beta Blocker for Congestive Heart Failure?
  • News

    • Mandeep Mehra MDCOVID-19 Co-Morbidity Risks Quantified from Three Continents SurveyMay 28, 2020
    • Ultrahypofractionated Radiation Just As Effective for Prostate CancerUltrahypofractionated Radiation Just As Effective for Prostate CancerMay 16, 2018
    • Paracetamol Poisoning: 12-hour modified acetylcysteine treatment for paracetamol poisoning reduced side effects associated with standard regimen.First evidence that genome editing made patients with AIDS more resistant to HIVMarch 8, 2014
    • Paracetamol Poisoning: 12-hour modified acetylcysteine treatment for paracetamol poisoning reduced side effects associated with standard regimen.Anticoagulation with warfarin can be beneficial in patients with atrial fibrillation and chronic kidney disease.March 7, 2014
    • Paracetamol Poisoning: 12-hour modified acetylcysteine treatment for paracetamol poisoning reduced side effects associated with standard regimen.Prostate cancer: Adult exposure to bisphenol-A linked to prostate cancer riskMarch 6, 2014
  • Related interviews

    • Microbiome Diversity Key To Survival After Allogeneic…
    • Ibrutinib: New Frontline Standard for Chronic Lymphocytic…
    • Genomic-led AML Clinical Decision Making Within Seven Days
    • New Front Line Standard for Older Patients with Chronic…
    • CT Screening Cuts Lung Cancer Deaths 24 Per Cent—Second…
  • Home
  • Cardiovascular
  • Enoxaparin Shows Safety in Angioplasty – STEEPLE Study

© Copyright 2022 AudioMedica.com. Typegrid Theme by WPBandit.